Presentation TCT 2017 NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters Presenter: Patricia J. Best October 30, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 ACS/AMI Up Next Presentation TCT 2017 Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors! Presenter: Dimitrios Alexopoulos October 30, 2017 More slides + Presentation TCT 2017 Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors! Presenter: Somjot S. Brar October 30, 2017 Presentation TCT 2017 Debate: DAPT Duration With Contemporary DES: Prolonged (>1 Year) DAPT for Most ACS Patients! Presenter: Robert W. Yeh October 30, 2017 We Recommend
Presentation TCT 2017 Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors! Presenter: Dimitrios Alexopoulos October 30, 2017
Presentation TCT 2017 Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors! Presenter: Somjot S. Brar October 30, 2017
Presentation TCT 2017 Debate: DAPT Duration With Contemporary DES: Prolonged (>1 Year) DAPT for Most ACS Patients! Presenter: Robert W. Yeh October 30, 2017